In contrast to RPs, most ADRs inhibited γH2AX and p-4EBP1 and activated p-AKT and p-STAT5, a signature suggesting activation of cell survival signaling that would be undesirable in an anti-cancer compound. The gene discussed is AKT1; the disease is cancer.